| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $372.8M | +44.4% |
| Cost of Revenue | $243.8M | +33.5% |
| Gross Profit | $129.0M | +70.8% |
| R&D Expense | $17.3M | +1.0% |
| SG&A Expense | $28.4M | -9.4% |
| Operating Income | $20.0M | +221.8% |
| Interest Expense | $8.3M | +1546.8% |
| Pre-tax Income | $10.7M | +161.5% |
| Income Tax | -$5.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.0M | -30.6% |
| Accounts Receivable | $93.1M | +71.2% |
| Inventory | $71.3M | +61.9% |
| Current Assets | $188.4M | +50.9% |
| Total Assets | $298.9M | +99.3% |
| Current Liabilities | $123.7M | +119.5% |
| Long-term Debt | $49.0M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.8M | -78.7% |
| Capital Expenditures | $4.9M | +127.6% |
| Investing Cash Flow | -$82.2M | -3707.7% |
| Financing Cash Flow | $71.1M | +498.1% |
| Free Cash Flow | $847K | -96.6% |
| -1730.5% |
| Net Income | $16.2M | +191.5% |
| EPS (Basic) | $0.81 | +178.6% |
| EPS (Diluted) | $0.78 | +175.7% |
| Total Liabilities |
| $178.3M |
| +174.7% |
| Stockholders' Equity | $120.6M | +41.8% |